Clik here to view.
Investment Bridge Announces Investment Opinion: Bridge Report on R-Tech Ueno...
TOKYO Investment Bridge, one of Japan’s leading independent IR services companies, has released a “Bridge Report” on R-Tech Ueno, Ltd. (JASDAQ:4573) reviewing the results for the fiscal year March...
View ArticleClik here to view.
Coronary Angiogram in Thailand by Phyathai Nawamin International Hospital
BANGKOK Phyathai Nawamin International Hospital in Thailand recommends Coronary Angiogram as the best way to treat Coronary artery disease. An angiogram is one of the most common diagnostic tests in...
View ArticleClik here to view.
Kapa Biosystems Strengthens Investment across Asia Pacific Region by...
WILMINGTON, Mass. Kapa Biosystems announced today that it has signed a new three-year exclusive distribution agreement with Nippon Genetics Co., Ltd., further extending the successful seven-year...
View ArticleClik here to view.
‘Wonli Acupuncture’ Suggests New Way to Overcome Spinal Stenosis without Bone...
SEOUL, South Korea Dr. Lee RATOC (Director, Geon-mok Lee) discovered a new treatment method for Lumbar spinal stenosis, named ‘Wonli Acupuncture.’ With increasing life span, Lumbar Spinal Stenosis...
View ArticleClik here to view.
Lombard Medical’s Aorfix™ Receives Regulatory Approval in Japan for Treatment...
IRVINE, Calif. & LONDON Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAA), today announced that...
View ArticleClik here to view.
NanoString Technologies Receives Market Approval From the Australian...
SEATTLE NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of life science tools for translational research and developer of molecular diagnostic products, today announced that it has received...
View ArticleClik here to view.
Toshiba’s New Technology Enables Blood Flow Visualization Never Thought...
LAKE BUENA VISTA, Fla. Toshiba is making it possible for clinicians to use ultrasound to see the smallest vessels in and around areas like tumors and lymph nodes, giving them a new way to diagnose...
View ArticleClik here to view.
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
REDWOOD CITY, Calif. Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has named veteran...
View ArticleClik here to view.
ZRG Partners Life Sciences Hiring Index Q2 Declines Slightly but Still Near...
WEST ORANGE, N.J. ZRG Partners, Inc. announces the results of its second quarter Global Life Sciences Hiring Index. Q2 displays a slightly negative turn but the overall outlook remains positive with...
View ArticleClik here to view.
CANCER RESEARCH UK AND CANCER RESEARCH TECHNOLOGY JOIN FORCES WITH ASTELLAS...
LONDON Cancer Research UK and its commercial arm, Cancer Research Technology (“CRT”), are to join forces with Astellas Pharma Inc. (Tokyo, President & CEO: Yoshihiko Hatanaka, “Astellas”) to...
View ArticleClik here to view.
FDA Approves VELCADE® (bortezomib) Retreatment in Patients with Multiple Myeloma
CAMBRIDGE, Mass. Millennium: The Takeda Oncology Company with its parent company, Takeda Pharmaceutical Company Limited (TSE:4502), today announced that the U.S. Food and Drug Administration (FDA)...
View ArticleClik here to view.
Cook Medical Enrolls First Patient in Zilver® PTX® Drug Eluting Peripheral...
BLOOMINGTON, Ind. Cook Medical has enrolled the first patient in the clinical study in China of its Zilver® PTX® Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal...
View ArticleClik here to view.
Fabrinet Announces Audit Committee Investigation into Accounting Matters;...
BANGKOK Fabrinet (NYSE:FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of...
View ArticleClik here to view.
Provectus Signs Memorandum of Understanding with Sinopharm-China State...
KNOXVILLE, Tenn. Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company (“Provectus”), announced today that...
View ArticleClik here to view.
New Promega Branch in India Brings Convenient Access to Technologies and...
MADISON, Wis. Promega Corporation announces its expansion into India with a 16th branch that serves the country’s scientific community with wide product availability, efficient delivery and...
View ArticleClik here to view.
Provectus 与国药-中国医药工业研究总院和 国药A-THINK Pharmaceuticals Co., Ltd.签署谅解备忘录
田纳西州诺克斯维尔 (美国商业资讯) — Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (http://www.pvct.com)是一家开发阶段肿瘤科和皮肤科生物制药公司(“Provectus”)。公司今天宣布已与国药-中国医药工业研究总院（国药-CSIPI，中国所有医药研究院中的领先者）和国药 A-THINK...
View ArticleClik here to view.
NovaBay Announces Results of NVC-422 Phase 2 for Viral Conjunctivitis
EMERYVILLE, Calif. NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY) announced today that its NVC-422 ophthalmic formulation did not meet the primary or secondary endpoints in a Phase 2 clinical study in...
View ArticleClik here to view.
QImaging Launches New Complete, Live Cell Imaging Solution
SURREY, Canada QImaging™ today launched a new, all-in-one camera package that supports demanding live cell fluorescence imaging requirements. The Live Cell Imaging Package provides researchers with...
View ArticleClik here to view.
Clik here to view.